South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales.

For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.

(Reporting by Promit Mukherjee; editing by Jason Neely)